Hep C medicines: too high a price to pay?

One of the key health-related tasks of the re-elected Coalition government will be to ensure a solution to the supply of the expensive new Hepatitis C medicines.The scale of the issue, simmering since the medicines were listed on the PBS on 1 March has been brought to light by a recent AJP poll that showed